Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dawson John Andrew | Director | 1 | $0 | $0 | 2026-10-18 |
| Ramsdell Deborah | Director | 1 | $0 | $0 | 2026-10-18 |
| Wendel Bruce | Director | 1 | $0 | $0 | 2026-10-18 |
| Shepard Kirk V. | Chief Medical Officer | 3 | $0 | $0 | 2026-01-12 |
| Brown Spencer D. | Senior VP, General Counsel | 5 | $0 | $0 | 2026-01-12 |
| Iliev Ilian | Director | 8 | $0 | $0 | 2026-01-12 |
| BEDU-ADDO FRANK | President/CEO | 14 | $0 | $0 | 2026-01-12 |
| CONN GREGORY | Chief Scientific Officer | 8 | $0 | $0 | 2026-01-12 |
| Toutain Stephan | Chief Operations Officer | 3 | $0 | $0 | 2026-01-12 |
| Ali-Jackson Kamil | Director | 9 | $100.0K | $0 | 2026-01-12 |
| Freitag Gregory Gene | Director | 12 | $75.0K | $0 | 2026-01-12 |
| Boesgaard Lars | Chief Financial Officer | 3 | $0 | $0 | 2026-01-12 |
| Glover Steve C | Director | 12 | $75.0K | $0 | 2026-01-12 |
| BRAWLEY OTIS W | Director | 7 | $0 | $0 | 2026-01-12 |
| SYKES RICHARD | Director | 7 | $0 | $0 | 2024-06-24 |
| WOOD LAUREN | Chief Medical Officer | 5 | $0 | $0 | 2023-01-05 |
| HILL MATTHEW C | Chief Financial Officer | 6 | $27.9K | $0 | 2023-01-05 |
| Bloomquist DeLyle W | Other | 5 | $98.8K | $0 | 2021-06-16 |
| VAN VOORHEES SETH | Chief Financial Officer | 2 | $150.0K | $0 | 2021-06-15 |
| King Michael N. | Interim CFO | 1 | $0 | $0 | 2020-12-08 |
| Saik Andrew | Chief Financial Officer | 2 | $0 | $0 | 2020-02-14 |
| LOUGHLIN JAMES J | Director | 1 | $0 | $0 | 2019-06-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ramsdell Deborah | Director | A Award deriv | 2026-10-18 | 2026-10-20 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Wendel Bruce | Director | A Award deriv | 2026-10-18 | 2026-10-20 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Dawson John Andrew | Director | A Award deriv | 2026-10-18 | 2026-10-21 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Glover Stephen C. | Director | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| Toutain Stephan | Chief Operating Officer | A Award deriv | 2026-01-12 | 2026-03-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Brown Spencer D. | Senior VP, General Counsel | A Award deriv | 2026-01-12 | 2026-03-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Boesgaard Lars | Chief Financial Officer | A Award deriv | 2026-01-12 | 2026-03-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Shepard Kirk V. | Chief Medical Officer | A Award deriv | 2026-01-12 | 2026-03-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2026-01-12 | 2026-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2026-01-12 | 2026-03-03 | 548,782 | — | $0 | 548,782 | SEC↗ |
| Toutain Stephan | Chief Operations Officer | A Award deriv | 2025-06-12 | 2025-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2025-06-12 | 2025-07-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Boesgaard Lars | Chief Financial Officer | A Award deriv | 2025-06-12 | 2025-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Brown Spencer D. | Senior VP, General Counsel | A Award deriv | 2025-06-12 | 2025-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Shepard Kirk V. | Chief Medical Officer | A Award deriv | 2025-06-12 | 2025-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2025-06-12 | 2025-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Glover Stephen C. | Director | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| Glover Stephen C. | Director | P Buy deriv | 2025-02-28 | 2025-03-03 | 15,061 | — | $0 | 15,061 | SEC↗ |
| Freitag Gregory Gene | Director | P Buy deriv | 2025-02-28 | 2025-03-03 | 15,060 | — | $0 | 15,060 | SEC↗ |
| Glover Stephen C. | Director | P Buy | 2025-02-28 | 2025-03-03 | 15,061 | $1.66 | $25.0K | 78,851 | SEC↗ |
| Freitag Gregory Gene | Director | P Buy | 2025-02-28 | 2025-03-03 | 15,060 | $1.66 | $25.0K | 61,213 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Stephen C. | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Toutain Stephan | Chief Operations Officer | A Award deriv | 2024-05-01 | 2024-05-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2024-02-28 | 2025-07-25 | 46,648 | — | $0 | 46,648 | SEC↗ |
| Brown Spencer D. | Senior VP, General Counsel | A Award deriv | 2024-02-28 | 2025-07-25 | 56,000 | — | $0 | 56,000 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2024-02-28 | 2025-07-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Shepard Kirk V. | Chief Medical Officer | A Award deriv | 2024-01-22 | 2024-01-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Boesgaard Lars | Chief Financial Officer | A Award deriv | 2023-12-04 | 2023-12-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Stephen C. | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| WOOD LAUREN | Chief Medical Officer | A Award deriv | 2023-01-05 | 2023-01-06 | 110,800 | — | $0 | 110,800 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2023-01-05 | 2023-01-06 | 385,300 | — | $0 | 385,300 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2023-01-05 | 2023-01-06 | 137,200 | — | $0 | 137,200 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | A Award deriv | 2023-01-05 | 2023-01-06 | 161,200 | — | $0 | 161,200 | SEC↗ |
| Brown Spencer D. | Senior VP, General Counsel | A Award deriv | 2023-01-05 | 2023-01-06 | 20,400 | — | $0 | 20,400 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | M Exercise deriv | 2022-12-02 | 2022-12-02 | 219,535 | — | $0 | 0 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | M Exercise | 2022-12-02 | 2022-12-02 | 219,535 | $6.57 | $1.44M | 866,050 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | F Tax w/h | 2022-12-02 | 2022-12-02 | 175,184 | $9.78 | $1.71M | 690,866 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Steve C | Director | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Brown Spencer D. | Senior VP, General Counsel | A Award deriv | 2022-06-02 | 2022-06-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| WOOD LAUREN | Chief Medical Officer | A Award deriv | 2022-01-19 | 2022-01-20 | 88,600 | — | $0 | 88,600 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2022-01-19 | 2022-01-20 | 291,500 | — | $0 | 291,500 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2022-01-19 | 2022-01-20 | 112,100 | — | $0 | 112,100 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | P Buy | 2021-12-13 | 2021-12-14 | 100 | $9.00 | $900 | 3,975 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | P Buy | 2021-12-13 | 2021-12-14 | 100 | $9.00 | $900 | 4,075 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | P Buy | 2021-12-13 | 2021-12-14 | 400 | $8.90 | $3.6K | 3,875 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | P Buy | 2021-12-13 | 2021-12-14 | 2,500 | $9.00 | $22.5K | 3,475 | SEC↗ |
| HILL MATTHEW C | Chief Financial Officer | A Award deriv | 2021-10-19 | 2021-10-20 | 202,800 | — | $0 | 202,800 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Steve C | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Bloomquist DeLyle W | Other | M Exercise deriv | 2021-06-16 | 2021-06-21 | 2,970 | — | $0 | 6,030 | SEC↗ |
| Bloomquist DeLyle W | Other | M Exercise | 2021-06-16 | 2021-06-21 | 2,970 | $5.99 | $17.8K | 183,888 | SEC↗ |
| Bloomquist DeLyle W | Other | P Buy | 2021-06-16 | 2021-06-21 | 10,000 | $9.88 | $98.8K | 193,888 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | M Exercise deriv | 2021-06-15 | 2021-06-17 | 53,174 | — | $0 | 0 | SEC↗ |
| Freitag Gregory Gene | Director | P Buy | 2021-06-15 | 2021-06-17 | 5,882 | $8.50 | $50.0K | 46,153 | SEC↗ |
| VAN VOORHEES SETH | Chief Financial Officer | P Buy | 2021-06-15 | 2021-06-17 | 17,647 | $8.50 | $150.0K | 17,647 | SEC↗ |
| Ali-Jackson Kamil | Director | P Buy | 2021-06-15 | 2021-06-17 | 11,764 | $8.50 | $100.0K | 11,764 | SEC↗ |
| Glover Steve C | Director | P Buy | 2021-06-15 | 2021-06-17 | 5,882 | $8.50 | $50.0K | 63,790 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | M Exercise | 2021-06-15 | 2021-06-17 | 53,174 | $6.57 | $349.4K | 673,681 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | F Tax w/h | 2021-06-15 | 2021-06-17 | 27,166 | $12.86 | $349.4K | 646,515 | SEC↗ |
| VAN VOORHEES SETH | Chief Financial Officer | A Award deriv | 2021-01-04 | 2021-01-06 | 202,800 | — | $0 | 202,800 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2020-12-08 | 2020-12-09 | 707,800 | — | $0 | 707,800 | SEC↗ |
| King Michael N. | Interim CFO | A Award deriv | 2020-12-08 | 2020-12-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| WOOD LAUREN | Chief Medical Officer | A Award deriv | 2020-12-08 | 2020-12-09 | 210,500 | — | $0 | 210,500 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2020-12-08 | 2020-12-09 | 122,400 | — | $0 | 122,400 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2020-11-03 | 2020-11-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2020-06-23 | 2020-06-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2020-06-23 | 2020-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 1,874 | — | $0 | 1,874 | SEC↗ |
| Bloomquist DeLyle W | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| WOOD LAUREN | Chief Medical Officer | A Award deriv | 2020-06-23 | 2020-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 3,033 | — | $0 | 3,033 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Steve C | Director | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Iliev Ilian | Director | A Award deriv | 2020-04-08 | 2020-04-09 | 4,500 | — | $0 | 4,500 | SEC↗ |
| Ali-Jackson Kamil | Director | A Award deriv | 2020-02-21 | 2020-02-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Steve C | Director | A Award | 2020-02-14 | 2020-02-19 | 38,400 | $1.30 | $49.9K | 57,908 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award | 2020-02-14 | 2020-02-19 | 38,400 | $1.30 | $49.9K | 42,549 | SEC↗ |
| SYKES RICHARD | Director | A Award | 2020-02-14 | 2020-02-19 | 384,615 | $1.30 | $500.0K | 445,108 | SEC↗ |
| Freitag Gregory Gene | Director | A Award | 2020-02-14 | 2020-02-19 | 38,400 | $1.30 | $49.9K | 40,271 | SEC↗ |
| Bloomquist DeLyle W | Director, 10% Owner | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BEDU-ADDO FRANK | President/CEO | A Award deriv | 2019-06-28 | 2019-07-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| LOUGHLIN JAMES J | Director | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYKES RICHARD | Director | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Glover Steve C | Director | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award deriv | 2019-06-06 | 2019-06-07 | 62,715 | — | $0 | 62,715 | SEC↗ |
| CONN GREGORY | Chief Scientific Officer | A Award deriv | 2019-06-06 | 2019-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| WOOD LAUREN | Chief Medical Officer | A Award deriv | 2019-06-06 | 2019-06-07 | 62,715 | — | $0 | 62,715 | SEC↗ |